Clinical Trial Update: VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 trial comparing valsartan to atenolol on exercise capacity in hypertensive overweight postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Diovan (valsartan) (valsartan)
• Tenormin (Atenolol) (atenolol)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED